BOPA Abstract deadline EXTENDED To midnight Sunday 14th July 2024

The deadline for abstracts for this year’s BOPA 2024 conference in Birmingham has been extended. Delegates are invited to present results of their clinical and technical work as a poster with some selected as an oral presentation.  The author/s should submit via the BOPA website by midnight on Sunday 14th July 2024.

Abstracts will be reviewed and marked by the BOPA Audit and Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal.

Further information can be found here

Latest News

By Suriya Marshall on 19th June 2026

Inclusion in Action: Cancer Pharmacy Champion – EDI award nominations 2026

Inclusion in Action: Cancer Pharmacy Champion – EDI award nominations We’re pleased to launch the BOPA EDI Excellence Award, recognising individuals and teams who are actively advancing equity, diversity and inclusion in cancer pharmacy. This…

Read article
By Suriya Marshall on 19th June 2026

BOPA Above & Beyond Awards 2026

The Above and Beyond Award celebrates individuals and teams going over and above what is expected of them in the workplace. It is to celebrate those achievements of BOPA members…

Read article
By BOPA Executive Committee on 16th June 2026

BOPA Fellowship Nominations 2026 are NOW OPEN!

We are pleased to announce that BOPA Fellowship Nominations have now opened for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing…

Read article
By Pharmaceutical Press (PhP) on 15th June 2026

Exciting new project with the Pharmaceutical Press (PhP)

Expressions of interest: We are currently seeking expressions of interest to support an exciting new project with the Pharmaceutical Press (PhP). PhP is developing a new resource to support healthcare…

Read article